4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone, 97.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 97%, 100mg

2-(Cyclobutylmethoxy)pyrimidine-5-carboxylic acid, 1g

6-methyl-1,3-benzoxazol-2(3H)-one, 250mg

3'',4'',5'',6''-TETRAKIS(4'-AMINO[1,1'-BIPHENYL]-4-YL)-[1,1':4',1'':2'',1''':4''',1''''-QUINQUEPHENYL]-4,4''''-DIAMINE, 95%, 250mg

3-(2-Methylpyrimidin-4-yl)benzenesulfonyl chloride, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-5, 30 m, 0,53 mm, 0,50 µm, 1 pièce(s)

(S)-3-Acetoxy-4-(trimethylammonio)butanoate hydrochloride, 95.0%, 1g

Hexyldimethyloctylammonium Bromide>97.0%(T)25g

8-Fluoro-1,2,3,4-tetrahydroquinoline hydrochloride, 95%, 5g

N1,N3-Dibenzylpropane-1,3-diamine, 95.0%, 5g

Rosiglitazone>98.0%(HPLC)(T)200mg

1-(5-methyl-2-pyridinyl)ethanone, 95.0%, 10g